Evidence map›Paper›PMID 22035199›Full record

ArticleJournal of neurochemistry2012

D(2)-Dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions.

Jeremy Celver, Meenakshi Sharma, Abraham Kovoor

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. G Protein-Coupled Receptor Dimerization-What Next?International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Plasma membrane compartmentalization of D2 dopamine receptors.The Journal of biological chemistry · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jeremy CelverDepartment of Biomedical and Pharmacological Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.
Meenakshi Sharma
Abraham Kovoor
University of Rhode Island · US

Funding

UNDERGRADUATE RESEARCH AND SEMINARSP20RR016457 · NCRR · UNIVERSITY OF RHODE ISLAND · PI ALMEIDA, KAREN H. · 2001 to 2011
$35.5M
A Genetic Test for Drug-Induced Dyskinesia Risk DeterminationR41MH078570 · NIMH · KOVOGEN · PI KOVOOR, ABRAHAM · 2006 to 2007
$507k
Development of A Novel Animal Model of Tardive DyskinesiaR15MH091639 · NIMH · UNIVERSITY OF RHODE ISLAND · PI KOVOOR, ABRAHAM · 2010 to 2010
$368k
NCRR NIH HHS P20 RR016457NCRR NIH HHS P20RR016457NIMH NIH HHS R15 MH091639NIMH NIH HHS R41 MH078570
6 · The paper itself

Abstract

Detergent-resistant membranes (DRM) are thought to contain structures such as lipid rafts that are involved in compartmentalizing cell membranes. We report that the majority of D(2)-dopamine receptors (D(2)R) expressed endogenously in mouse striatum or expressed in immortalized cell-lines is found in DRM. In addition, exogenous co-expression of D(2)R in a cell line shifted the expression of regulator of G protein signaling 9-2 (RGS9-2) into DRM. RGS9-2 is a protein that is highly enriched in the striatum and specifically regulates striatal D(2)R. In the striatum, RGS9-2 is mostly associated with DRMs but when expressed in cell lines, RGS9-2 is present in the soluble cytoplasmic fraction. In contrast, the majority of mu opioid receptors and delta opioid receptors are found in detergent-soluble membrane and there was no shift of RGS9-2 into DRM after co-expression of mu opioid receptor. These data suggest that the targeting of RGS9-2 to DRM in the striatum is mediated by D(2)R and that DRM is involved in the formation of a D(2)R signaling complex. D(2)R-mediated targeting of RGS9-2 to DRM was blocked by the deletion of the RGS9-2 DEP domain or by a point mutation that abolishes the GTPase accelerating protein function of RGS9-2.

Indexed as

Blotting, WesternBrain ChemistryCell LineCell MembraneCorpus StriatumDetergentsDNA, ComplementaryGTP-Binding Protein beta SubunitsHumansImmunohistochemistryMembrane ProteinsMutationOctoxynolReceptors, Dopamine D2Receptors, Opioid, deltaReceptors, Opioid, muDetergentsDNA, ComplementaryGNB5 protein, humanGTP-Binding Protein beta SubunitsMembrane ProteinsOctoxynolReceptors, Dopamine D2Receptors, Opioid, deltaReceptors, Opioid, muregulator of g-protein signaling 9RGS Proteins

Identifiers

PMID22035199
PMCPMC3240708
OpenAlexW1898347331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.